Close

Wedbush Upgrades Docusign (DOCU) to Neutral as Negative Catalysts Have Played Out and Could Be M&A Target

October 12, 2022 6:32 AM EDT Send to a Friend
Wedbush analyst Daniel Ives upgraded Docusign Inc. (NASDAQ: DOCU) from Underperform to Neutral with a price target of $55, saying ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login